Neumora Therapeutics, Common Stock Price Transform Weighted Close Price
| NMRA Stock | 10.52 0.13 1.25% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Developed by Larry Williams, the Weighted Close is the average of Neumora Therapeutics, high, low and close of a chart with the close values weighted twice. It can be used to smooth an indicator that normally takes only Neumora Therapeutics, closing price as input.
Neumora Therapeutics, Technical Analysis Modules
Most technical analysis of Neumora Therapeutics, help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neumora from various momentum indicators to cycle indicators. When you analyze Neumora charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neumora Therapeutics, Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neumora Therapeutics, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neumora Therapeutics, Common based on widely used predictive technical indicators. In general, we focus on analyzing Neumora Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neumora Therapeutics,'s daily price indicators and compare them against related drivers, such as price transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Neumora Therapeutics,'s intrinsic value. In addition to deriving basic predictive indicators for Neumora Therapeutics,, we also check how macroeconomic factors affect Neumora Therapeutics, price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2010 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.95 | 0.38 | 1.98 | 2.08 | Days Of Inventory On Hand | 29.42 | 6.77 | 7.78 | 7.39 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neumora Therapeutics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neumora Therapeutics,'s short interest history, or implied volatility extrapolated from Neumora Therapeutics, options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | FinTech Invested over 40 shares | |
 | Momentum Invested over 50 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested over 40 shares | |
 | Blockchain Invested few shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Trump Equities Invested few shares | |
 | Investing Invested few shares | |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neumora Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neumora Therapeutics,. If investors know Neumora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neumora Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.20) | Return On Assets (0.38) | Return On Equity (0.77) |
The market value of Neumora Therapeutics, is measured differently than its book value, which is the value of Neumora that is recorded on the company's balance sheet. Investors also form their own opinion of Neumora Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Neumora Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neumora Therapeutics,'s market value can be influenced by many factors that don't directly affect Neumora Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neumora Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Neumora Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neumora Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.